Showing 3581-3590 of 9661 results for "".
- Leading Melanoma Groups Unveil New Campaign Aimed at Menhttps://practicaldermatology.com/news/20120515-leading_melanoma_groups_unveil_new_campaign_aimed_at_men/2459800/
- Health Canada Approves BMS' Yervoy forhttps://practicaldermatology.com/news/20120208-health_canada_approves_bms_yervoy_for/2459870/
- Remibrutinib Maintains Efficacy Through Week 52 in Phase III CIndU Trialhttps://practicaldermatology.com/news/remibrutinib-maintains-efficacy-through-week-52-in-phase-iii-cindu-trial/2489032/Novartis announced new 52-week Phase III RemIND results showing sustained efficacy of Rhapsido (remibrutinib) in patients with chronic inducible urticaria (CIndU), including symptomatic dermographism (SD), cold urticaria (ColdU), and cholinergic urticaria (CholU). The findings, announced b
- Study: Morphea Linked to Elevated Cancer Incidencehttps://practicaldermatology.com/news/study-morphea-linked-to-elevated-cancer-incidence/2489017/Patients with morphea and systemic sclerosis (SSc) have an increased incidence of cancer compared with the general population, according to a population-based cohort study published in JAMA Dermatology. Researchers analyzed linked administrative health databases from Quebec, Canad
- Microneedling Combined With Plant-Derived Exosomes Shows Hair Growth Improvements in Small Case Serieshttps://practicaldermatology.com/news/microneedling-combined-with-plant-derived-exosomes-shows-hair-growth-improvements-in-small-case-series/2488949/A two-patient case series evaluating microneedling combined with topical plant-derived exosomes reported improvements in hair coverage and shedding among patients with androgenetic alopecia and early traction alopecia. The findings provide preliminary observations on the combination approach, alt
- Stacey Moore and Dr. Susan Taylor Launch "Polished Not Perfect" Podcast on Leadership, Careers, and Lifehttps://practicaldermatology.com/news/stacey-moore-and-dr-susan-taylor-launch-polished-not-perfect-podcast-on-leadership-careers-and-life/2488943/Healthcare communications executive Stacey Moore and dermatologist Susan Taylor, MD, FAAD, have launched Polished Not Perfect, a podcast exploring the professional and personal challenges of career advancement, leadership, and balancing competing responsibilities. Longtime friends and esta
- Study: Pediatric Patients With Moderate-to-Severe Psoriasis Receive Fewer Systemic Therapieshttps://practicaldermatology.com/news/study-pediatric-patients-with-moderate-to-severe-psoriasis-receive-fewer-systemic-therapies/2488925/A real-world US survey found significant differences in plaque psoriasis severity and treatment patterns between pediatric and adult patients, with children receiving fewer systemic therapies than adults even among those with moderate-to-severe disease. The findings, published in the J
- Rosacea Severity Linked to Metabolic Syndrome in New Cohort Studyhttps://practicaldermatology.com/news/rosacea-severity-linked-to-metabolic-syndrome-in-new-cohort-study/2488901/New research shows associations between rosacea severity, systemic inflammation, and metabolic syndrome. Published in Clinical, Cosmetic and Investigational Dermatology, the study included 298 patients with rosacea treated at a tertiary dermatology clinic in China between 2021 and
- International Consensus Clarifies Melasma Treatment Safety in Vitiligohttps://practicaldermatology.com/news/international-consensus-clarifies-melasma-treatment-safety-in-vitiligo/2488900/An international expert consensus sought to outline treatment strategies for patients with coexisting vitiligo and melasma, emphasizing disease activity, individualized treatment sequencing, and caution with depigmenting therapies. Researchers conducted a scoping literature review through
- PET/CT Shows High Specificity in Pediatric Melanoma Imaginghttps://practicaldermatology.com/news/pediatric-melanoma-imaging-petct-shows-high-specificity/2488829/A single-center retrospective study published in Children found that 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) demonstrated 90.3% diagnostic accuracy for detecting clinically active disease in children and adolescents with malignant melanoma.